OTCMKTS:PKPH

Peak Pharmaceuticals Stock Forecast, Price & News

$0.11

0.00 (-0.18 %)

(As of 05/14/2021 03:53 PM ET)

Add

Compare

Today's Range

$0.11

▼

$0.12

50-Day Range

$0.10

▼

$0.16

52-Week Range

$0.01

▼

$0.27

Volume33,359 shs

Average Volume363,646 shs

Market Capitalization$8.60 million

P/E RatioN/A

Dividend YieldN/A

Beta0.46

30 days | 90 days | 365 days | Advanced Chart

Receive PKPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

About Peak Pharmaceuticals

Peak Pharmaceuticals, Inc. operates as a bioÂpharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCÂfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.

Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 2.7%
May 11, 2021 | americanbankingnews.com

Parallel's goodblend Texas To Roll Out First Medical Cannabis Capsules In Texas
May 5, 2021 | benzinga.com

UCSF Launches New Psychedelic Research Division
April 26, 2021 | benzinga.com

Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree
April 8, 2021 | benzinga.com

Cannabis Legalization Is Extremely Popular In France
April 7, 2021 | benzinga.com

New York Strikes Marijuana Reform Deal Paving Way For Adult-Use Bill
March 26, 2021 | benzinga.com

Item 9 Closes Merger With ONE Cannabis Group, Expands Distribution Through Unity Rd.
March 25, 2021 | benzinga.com

Hexo Stock Moves On Q2 Results: Technical Levels To Watch
March 20, 2021 | benzinga.com

Verano Raises CA$100M Selling Warrants Co-Led By Beacon Securities, Canaccord Genuity
March 13, 2021 | benzinga.com

Psyched: MindMed Enters Psychedelics 2.0, Mind Cure Raises $18M, Mydecine Raises $13M
February 19, 2021 | benzinga.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryCannabis

SectorMedical

Current SymbolOTCMKTS:PKPH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.peakpharma.com

Phone480-659-6404

Employees1

Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Miscellaneous

Outstanding Shares78,360,000

Market Cap$8.60 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.74 out of 5 stars

Medical Sector

1263rd out of 2,039 stocks

Pharmaceutical Preparations Industry

549th out of 769 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Peak Pharmaceuticals.

3.7 Community Rank

Outperform Votes
Peak Pharmaceuticals has received 110 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Peak Pharmaceuticals has received 39 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Peak Pharmaceuticals has received 73.83% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Peak Pharmaceuticals and other stocks. Vote “Outperform” if you believe PKPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PKPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Peak Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Peak Pharmaceuticals does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Peak Pharmaceuticals insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Peak Pharmaceuticals (OTCMKTS:PKPH) Frequently Asked Questions

What stocks does MarketBeat like better than Peak Pharmaceuticals?

Wall Street analysts have given Peak Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Peak Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Peak Pharmaceuticals' stock been impacted by Coronavirus?

Peak Pharmaceuticals' stock was trading at $0.0176 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PKPH shares have increased by 523.9% and is now trading at $0.1098.
View which stocks have been most impacted by COVID-19.

Who are Peak Pharmaceuticals' key executives?

Peak Pharmaceuticals' management team includes the following people:

Mr. Neil T. Reithinger, CEO, Pres, CFO, Principal Accounting Officer, Treasurer, Sec. & Director (Age 51)

Who are some of Peak Pharmaceuticals' key competitors?

Some companies that are related to Peak Pharmaceuticals include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), Leaf Mobile (LEAF), GrowGeneration (GRWG), OrganiGram (OGI), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), Terra Tech (TRTC), NSAV (NSAV), General Cannabis (CANN), Pervasip (PVSP) and Grow Capital (GRWC).
View all of PKPH's competitors.

What other stocks do shareholders of Peak Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Peak Pharmaceuticals investors own include Cannabics Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), Medical Marijuana (MJNA), OrganiGram (OGI), Auxly Cannabis Group (CBWTF), GB Sciences (GBLX), GreenGro Technologies (GRNH), KushCo (KSHB) and MariMed (MRMD).

What is Peak Pharmaceuticals' stock symbol?

Peak Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PKPH."

How do I buy shares of Peak Pharmaceuticals?

Shares of PKPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Peak Pharmaceuticals' stock price today?

One share of PKPH stock can currently be purchased for approximately $0.11.

How much money does Peak Pharmaceuticals make?

Peak Pharmaceuticals has a market capitalization of $8.60 million.

How many employees does Peak Pharmaceuticals have?

Peak Pharmaceuticals employs 1 workers across the globe.

What is Peak Pharmaceuticals' official website?

The official website for Peak Pharmaceuticals is www.peakpharma.com.

Where are Peak Pharmaceuticals' headquarters?

Peak Pharmaceuticals is headquartered at 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260.

How can I contact Peak Pharmaceuticals?

Peak Pharmaceuticals' mailing address is 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-659-6404 or via email at [email protected]

This page was last updated on 5/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Peak Pharmaceuticals Stock Forecast, Price & News

Adding

Adding

Adding Peak Pharmaceuticals, Inc.

About Peak Pharmaceuticals

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

3.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment